Clomiphene citrate is used to help women become pregnant by stimulating the release of eggs from the ovaries. It's also sometimes used to treat low testosterone in men.[1] Clomid is currently being investigated across 11 indications[3], with its most advanced program in Phase 3.[1]
Clomid is one of 224 small molecule programs targeting Female Infertility. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
332 competitors in Treatment
Clomid
Biltricide
Dexilant
Niclocide
Minipress
Alfenta
Intuniv
Aurlumyn
Lotemax
Norpramin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources